Significance of Co-expression of Epidermal Growth Factor Receptor and Ki67 on Clinical Outcome in Patients With Anal Cancer Treated With Chemoradiotherapy: An Analysis of NRG Oncology RTOG 9811

Growth Factor ◽

Epidermal Growth Factor ◽

Clinical Outcome ◽

Anal Cancer ◽

Growth Factor Receptor ◽

The Significance of Coexpression of Epidermal Growth Factor Receptor (EGFR) and Ki67 on Clinical Outcome in Patients With Anal Cancer Treated With Chemoradiation Therapy: An Analysis of RTOG 98-11

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2012.07.374 ◽

2012 ◽

Vol 84 (3) ◽

pp. S145 ◽

Cited By ~ 1

Author(s):

C. Doll ◽

J. Moughan ◽

A.C. Klimowicz ◽

S.P. Lees-Miller ◽

J.A. Ajani ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Clinical Outcome ◽

Anal Cancer ◽

Growth Factor Receptor ◽

Chemoradiation Therapy ◽

Epidermal growth factor receptor activity and clinical outcome in glioblastoma and meningioma

British Journal of Neurosurgery ◽

10.3109/02688699309103479 ◽

1993 ◽

Vol 7 (2) ◽

pp. 197-199 ◽

Cited By ~ 18

Author(s):

Neil L. Dorward ◽

R. A. Hawkins ◽

Ian R. Whittle

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Clinical Outcome ◽

Growth Factor Receptor ◽

Receptor Activity ◽

Epidermal growth factor receptor in adrenocortical tumors: analysis of gene sequence, protein expression and correlation with clinical outcome

Yearbook of Endocrinology ◽

10.1016/j.yend.2011.06.045 ◽

2011 ◽

Vol 2011 ◽

pp. 246-247

Author(s):

D.E. Schteingart

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Clinical Outcome ◽

Protein Expression ◽

Gene Sequence ◽

Growth Factor Receptor ◽

Adrenocortical Tumors ◽

Epidermal growth factor receptor inhibition in metastatic anal cancer

Anti-Cancer Drugs ◽

10.1097/cad.0000000000000383 ◽

2016 ◽

Vol 27 (8) ◽

pp. 804-808 ◽

Cited By ~ 13

Author(s):

Jane E. Rogers ◽

Aki Ohinata ◽

Ninoska N. Silva ◽

Amir Mehdizadeh ◽

Cathy Eng

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Anal Cancer ◽

Growth Factor Receptor ◽

Receptor Inhibition ◽

Association of Cyclin D1 (CCND1) gene A870G polymorphism and clinical outcome of EGFR-positive metastatic colorectal cancer patients treated with epidermal growth factor receptor (EGFR) inhibitor cetuximab (C225)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.3518 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 3518-3518 ◽

Cited By ~ 3

Author(s):

W. Zhang ◽

J. Yun ◽

O. A. Press ◽

M. Gordon ◽

D. Y. Yang ◽

...

Keyword(s):

Colorectal Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Clinical Outcome ◽

Growth Factor Receptor ◽

Egfr Inhibitor ◽

Ccnd1 Gene ◽

Epidermal Growth ◽

Colorectal Cancer Patients

Epidermal growth factor receptor, phosphatidylinositol-3-kinase catalytic subunit/PTEN, and KRAS/NRAS/BRAF in primary resected esophageal adenocarcinomas: loss of PTEN is associated with worse clinical outcome

Human Pathology ◽

10.1016/j.humpath.2012.08.005 ◽

2013 ◽

Vol 44 (5) ◽

pp. 829-836 ◽

Cited By ~ 21

Author(s):

Marcus Bettstetter ◽

Sabina Berezowska ◽

Gisela Keller ◽

Axel Walch ◽

Annette Feuchtinger ◽

...

Keyword(s):

Growth Factor ◽

Epidermal Growth Factor ◽

Clinical Outcome ◽

Growth Factor Receptor ◽

Catalytic Subunit ◽

Phosphatidylinositol 3 Kinase ◽

Epidermal Growth ◽

Phosphatidylinositol 3

Beyond RAS: The Role of Epidermal Growth Factor Receptor (EGFR) and its Network in the Prediction of Clinical Outcome During Anti-EGFR Treatment in Colorectal Cancer Patients

Current Drug Targets ◽

10.2174/1389450115666141109212801 ◽

2014 ◽

Vol 15 (13) ◽

pp. 1225-1230 ◽

Cited By ~ 5

Author(s):

Riccardo Giampieri ◽

Giuseppe Aprile ◽

Michela Prete ◽

Luca Faloppi ◽

Maristella Bianconi ◽

...

Keyword(s):

Colorectal Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Clinical Outcome ◽

Cancer Patients ◽

Growth Factor Receptor ◽

Epidermal Growth ◽

Colorectal Cancer Patients

Association of Cyclin D1 (CCND1) gene A870G polymorphism and clinical outcome of EGFR-positive metastatic colorectal cancer patients treated with epidermal growth factor receptor (EGFR) inhibitor cetuximab (C225)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.3518 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 3518-3518

Author(s):

W. Zhang ◽

J. Yun ◽

O. A. Press ◽

M. Gordon ◽

D. Y. Yang ◽

...

Keyword(s):

Colorectal Cancer ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Clinical Outcome ◽

Growth Factor Receptor ◽

Egfr Inhibitor ◽

Ccnd1 Gene ◽

Epidermal Growth ◽

Colorectal Cancer Patients

Epidermal growth factor-receptor mutations and the clinical outcome in male smokers with squamous cell carcinoma of lung

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.22136 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 22136-22136 ◽

Cited By ~ 1

Author(s):

J. Hong ◽

Y. Kim ◽

S. Park ◽

E. Cho ◽

D. Shin

Keyword(s):

Squamous Cell Carcinoma ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Clinical Outcome ◽

Cell Carcinoma ◽

Squamous Cell ◽

Growth Factor Receptor ◽

Epidermal Growth Factor Receptor Mutations and the Clinical Outcome in Male Smokers with Squamous Cell Carcinoma of Lung

Journal of Korean Medical Science ◽

10.3346/jkms.2009.24.3.448 ◽

2009 ◽

Vol 24 (3) ◽

pp. 448 ◽

Cited By ~ 43

Author(s):

Se Hoon Park ◽

Seung Yeon Ha ◽

Jae-Ik Lee ◽

Hyewon Lee ◽

Hoyong Sim ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Growth Factor ◽

Epidermal Growth Factor ◽

Clinical Outcome ◽

Cell Carcinoma ◽

Squamous Cell ◽

Growth Factor Receptor ◽